arrow
D

David G. Pfister

Memorial Sloan Kettering Cancer Center
H指数:86
被引数:3.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of dual Medicare and Medicaid eligibility status on mortality for cancer patients across hospital types in the USA: a retrospective cohort study

美国不同类型医院中,同时具备医疗保险和医疗补助资格状态对癌症患者死亡率的影响:一项回顾性队列研究

2026-05-010
PRE
Anti-PD-1 antibody penpulimab plus chemotherapy for recurrent or metastatic nasopharyngeal carcinoma: a randomized, double-blind phase 3 study

Anti-PD-1抗体penpulimab联合化疗治疗复发或转移性鼻咽癌: 一项随机双盲3期研究

2026-04-080
OAAI
Defining response-adapted surgery after neoadjuvant systemic therapy in sinonasal squamous cell carcinoma

定义鼻窦鳞状细胞癌新辅助全身治疗后反应适应性手术

2026-02-010
PRE
Pathologic Response to Neoadjuvant Cetuximab, Platinum, and Taxane in Locally Advanced HNSCC

对局部晚期HNSCC应用新辅助西妥昔单抗、铂类药物和紫杉类药物的病理学反应

2025-10-170
PRE
Prospective Trial Evaluating Post-operative Human Papilloma Virus Circulating Tumor DNA Guided Adjuvant Therapy for Human Papilloma Virus-related Oropharyngeal Carcinoma (PATH study)

前瞻性试验评估基于术后人乳头瘤病毒循环肿瘤DNA指导的辅助治疗对与人乳头瘤病毒相关口咽癌的效果(PATH研究)

2025-10-010
PRE
Analysis of ASCL1/NEUROD1/POU2F3/YAP1 Yields Novel Insights for the Diagnosis of Olfactory Neuroblastoma and Identifies Sinonasal Tuft Cell-Like Carcinoma
2025-03-010
PRE
Head and Neck Cancers, Version 2.2025 Featured Updates to the NCCN Guidelines

头颈癌,版本2.2025:NCCN指南特色更新

2025-02-012
PRE
Reply by Authors
2024-03-010
PRE
International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors

过敏和鼻科的国际共识声明: 鼻窦肿瘤

2024-01-0249
OA